Eli Lilly's GLP-1 weight-loss pill could face off against Wegovy this spring

By Allison Bell

News December 08, 2025 at 05:54 PM

Share & Print

What You Need To Know

Eli Lilly also makes a weight-loss drug incorporating tirzepatide, which may be more effective than semaglutide.
The new drug is probably easier to take than Rybelsus, a GLP-1 agonist which is already available.
Novo Nordisk, the maker of Wegovy, is seeking FDA approval for an oral form of Wegovy.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.